SlideShare a Scribd company logo
1 of 3
Download to read offline
Colesevelam - Comprehensive patent search
Report Details:
Published:November 2012
No. of Pages:
Price: Single User License – US$7200




Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and
without the wait.
Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline
Developer minimises the risk of wasted developments or legal action, by providing you with
nothing less than the very best in comprehensive patent information. Searched and analysed by
highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer
delivers results you can rely on. And that means your staff can concentrate on how the patent
landscape affects your business, rather than trying to source reliable patent information.
Pipeline Developer features:
•Comprehensive patent searching, covering the world's key territories (see 'search coverage'
 below)
•Identifies patents covering molecule, formulation, process, use, combination and assay
 techniques (see 'Patent Categories Identified'below)
•Patent identification, categorisation and interpretation
•Grouped by patent family and assigned to development categories based on Interpretation of key
 aspects of the patent claims
•Manual filtration of patents not relevant to generic development
•Updated on a monthly basis, including changes to patent families, statuses, and litigation
•Enables fast analysis and verification by hyper-linking to crucial patent documents and national
 registers
Patent Categories Identified:
1. Molecular Form
 a) Molecule Patents
 b) Salts, Hydrates & Solvates
 c) Polymorphic Forms
 d) Other Molecular Forms
2. Active Ingredient Preparation
 a) Intermediates & Preparation Thereof
 b) Final Synthetic Stages
 c) Complete Synthesis
 d) Purification Methods
e) Fermentation Methods
 f) Biotechnology
3. Formulations & Methods Thereof
 a) General Formulations & Methods
 b) Injectable Formulations
 c) Oral Formulations
 d) Other Administration-Specific Formulations
 e) Excipients, Kits & Packaging
4. Related Medical Use & Administration
 a) New Use Related to Main Indication
 b) Dosing Regimen/Administration Conditions
5. Active Ingredient Combinations
 a) Novel Combinations
 b) Use of Combinations
 c) Dosing Regimen & Administration Conditions for Combinations
6. Analytical Methods
 a) Assaying Methods
 b) Methods of Determining Patient Suitability
Search coverage:
Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent
Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that
are individually verified and monitored for changes, including British, German, Spanish, French,
US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated.
'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC
database, increasing the search coverage to 70 countries.
Patent and national register access:
Clicking on a listed patent/application number or text or image link will launch a pop-up window
containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a
register link launches a pop-up window with the patent office register extract for that patent. This
allows investigation into the examination status of a pending patent, opposition of a granted patent
and/or payment of maintenance fees. Please note that no extra charges apply to accessing or
downloading documents of any kind.
Litigation alerts:
Informing you of developments in court, litigation alerts can also be accessed by clicking on the
litigation symbol next to the status, with links to judgements where available.
Updating:
To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline
Developer reporting is updated on a monthly basis. Convenient change flags identify new patent
families, new patent family members, changes in statuses and litigation alerts.
Legal status and transaction history:
You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by
clicking on the INPADOC Family/Legal Status button for 65 additional territories.
Reporting and access:
All data can be exported into Microsoft Excel and print friendly versions for ease of data
manipulation and reporting. Company details are confidential and all data is SSL secure. Five
users per company are permitted and access levels are controlled by a nominated 'company
administrator'.
Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent
Intelligence product suite.

Get your copy of this report @
http://www.reportsnreports.com/reports/206870-colesevelam--comprehensive-patent-search.html

Major points covered in Table of Contents of this report include
N/A


Contact: sales@reportsandreports.com for more information.

More Related Content

What's hot

American CryoStem 2016 Year End Update
American CryoStem 2016 Year End UpdateAmerican CryoStem 2016 Year End Update
American CryoStem 2016 Year End UpdateAmericanCryoStem
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Rose088
 
Practical XEVMPD experience; once upon a time there was a perfectly clean dat...
Practical XEVMPD experience; once upon a time there was a perfectly clean dat...Practical XEVMPD experience; once upon a time there was a perfectly clean dat...
Practical XEVMPD experience; once upon a time there was a perfectly clean dat...Qdossier B.V.
 
Clinical sas course syllabus
Clinical sas course syllabusClinical sas course syllabus
Clinical sas course syllabusSoftlogic Systems
 
IDMP and RIM: friend or foe?
IDMP and RIM: friend or foe?IDMP and RIM: friend or foe?
IDMP and RIM: friend or foe?eCTDconsultancy
 
E2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTSE2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTSAnurag Raghuvanshi
 
Incorporating Commercial and Private Data into an Open Linked Data Platform f...
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Incorporating Commercial and Private Data into an Open Linked Data Platform f...
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Alasdair Gray
 
FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11 FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11 EduQuest, Inc.
 
FDA's top data integrity issues during the inspections
FDA's top data integrity issues during the inspectionsFDA's top data integrity issues during the inspections
FDA's top data integrity issues during the inspectionsKiran Kota
 
Investigating future prospects of electronic medical device labeling
Investigating future prospects of electronic medical device labelingInvestigating future prospects of electronic medical device labeling
Investigating future prospects of electronic medical device labelingMyron Finseth, MSc
 
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Perficient
 
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
 
How to Comply with IDMP Regulatory Requirements
How to Comply with IDMP Regulatory RequirementsHow to Comply with IDMP Regulatory Requirements
How to Comply with IDMP Regulatory RequirementsPerficient, Inc.
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088
 
Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges: Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges: santoshnarla
 

What's hot (20)

American CryoStem 2016 Year End Update
American CryoStem 2016 Year End UpdateAmerican CryoStem 2016 Year End Update
American CryoStem 2016 Year End Update
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
 
Practical XEVMPD experience; once upon a time there was a perfectly clean dat...
Practical XEVMPD experience; once upon a time there was a perfectly clean dat...Practical XEVMPD experience; once upon a time there was a perfectly clean dat...
Practical XEVMPD experience; once upon a time there was a perfectly clean dat...
 
Clinical sas course syllabus
Clinical sas course syllabusClinical sas course syllabus
Clinical sas course syllabus
 
IDMP and RIM: friend or foe?
IDMP and RIM: friend or foe?IDMP and RIM: friend or foe?
IDMP and RIM: friend or foe?
 
E2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTSE2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTS
 
Lab data integrity
Lab data integrity Lab data integrity
Lab data integrity
 
Incorporating Commercial and Private Data into an Open Linked Data Platform f...
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Incorporating Commercial and Private Data into an Open Linked Data Platform f...
Incorporating Commercial and Private Data into an Open Linked Data Platform f...
 
Data integrity
Data integrityData integrity
Data integrity
 
FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11 FDA Data Integrity: Misconceptions of 21 CFR Part 11
FDA Data Integrity: Misconceptions of 21 CFR Part 11
 
FDA's top data integrity issues during the inspections
FDA's top data integrity issues during the inspectionsFDA's top data integrity issues during the inspections
FDA's top data integrity issues during the inspections
 
Investigating future prospects of electronic medical device labeling
Investigating future prospects of electronic medical device labelingInvestigating future prospects of electronic medical device labeling
Investigating future prospects of electronic medical device labeling
 
Data integrity nishodh 01092016
Data integrity nishodh 01092016Data integrity nishodh 01092016
Data integrity nishodh 01092016
 
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...
 
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...
 
How to Comply with IDMP Regulatory Requirements
How to Comply with IDMP Regulatory RequirementsHow to Comply with IDMP Regulatory Requirements
How to Comply with IDMP Regulatory Requirements
 
Abaxis press release
Abaxis press releaseAbaxis press release
Abaxis press release
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
 
Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges: Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges:
 
Delta GMP Data Integrity Sept2016
Delta GMP Data Integrity Sept2016Delta GMP Data Integrity Sept2016
Delta GMP Data Integrity Sept2016
 

Viewers also liked

TIt's the end of teh left, as we know it, and we should feel fine
TIt's the end of teh left, as we know it, and we should feel fineTIt's the end of teh left, as we know it, and we should feel fine
TIt's the end of teh left, as we know it, and we should feel finewww.mathisoberhof.wordpress.com
 
Technacolour tees brochure 2011 v1 2
Technacolour tees brochure 2011 v1 2Technacolour tees brochure 2011 v1 2
Technacolour tees brochure 2011 v1 2Doug Peters
 
Ge sinfonia patagonica
Ge sinfonia patagonicaGe sinfonia patagonica
Ge sinfonia patagonicaAlicia Cacace
 
China Express Delivery Industry Report, 2012
China Express Delivery Industry Report, 2012China Express Delivery Industry Report, 2012
China Express Delivery Industry Report, 2012ReportsnReports
 
Procure Doutor - Formatos de Publicidade
Procure Doutor - Formatos de PublicidadeProcure Doutor - Formatos de Publicidade
Procure Doutor - Formatos de PublicidadeProcure Doutor
 
Управление проектами в SEO
Управление проектами в SEOУправление проектами в SEO
Управление проектами в SEOMegaIndexTV
 

Viewers also liked (8)

The Creative Economy: Ideas, Industry & Innovation
The Creative Economy: Ideas, Industry & InnovationThe Creative Economy: Ideas, Industry & Innovation
The Creative Economy: Ideas, Industry & Innovation
 
TIt's the end of teh left, as we know it, and we should feel fine
TIt's the end of teh left, as we know it, and we should feel fineTIt's the end of teh left, as we know it, and we should feel fine
TIt's the end of teh left, as we know it, and we should feel fine
 
Declaração de irpf
Declaração de irpfDeclaração de irpf
Declaração de irpf
 
Technacolour tees brochure 2011 v1 2
Technacolour tees brochure 2011 v1 2Technacolour tees brochure 2011 v1 2
Technacolour tees brochure 2011 v1 2
 
Ge sinfonia patagonica
Ge sinfonia patagonicaGe sinfonia patagonica
Ge sinfonia patagonica
 
China Express Delivery Industry Report, 2012
China Express Delivery Industry Report, 2012China Express Delivery Industry Report, 2012
China Express Delivery Industry Report, 2012
 
Procure Doutor - Formatos de Publicidade
Procure Doutor - Formatos de PublicidadeProcure Doutor - Formatos de Publicidade
Procure Doutor - Formatos de Publicidade
 
Управление проектами в SEO
Управление проектами в SEOУправление проектами в SEO
Управление проектами в SEO
 

Similar to Colesevelam patent search

Implementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentImplementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentTechWell
 
Demo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationDemo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationGlobal Manager Group
 
Gaining business excellence by leveraging plm platform
Gaining business excellence by leveraging plm platformGaining business excellence by leveraging plm platform
Gaining business excellence by leveraging plm platformSimba Events
 
Maintaining A Materials Declaration System
Maintaining A Materials Declaration SystemMaintaining A Materials Declaration System
Maintaining A Materials Declaration Systemraj takhar
 
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...dclsocialmedia
 
handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...
handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...
handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...HERNANALBERTOTELLEZV
 
Maetrics: The ROI of Good Quality & Compliance
Maetrics: The ROI of Good Quality & ComplianceMaetrics: The ROI of Good Quality & Compliance
Maetrics: The ROI of Good Quality & ComplianceGeneris
 
Aagami Inc. Research Services Presentation
Aagami Inc. Research Services PresentationAagami Inc. Research Services Presentation
Aagami Inc. Research Services PresentationGodwyn Francis
 
Generis Company Presentation for RIM
Generis Company Presentation for RIMGeneris Company Presentation for RIM
Generis Company Presentation for RIMGeneris
 
Adalimumab- comprehensive patent search
Adalimumab- comprehensive patent searchAdalimumab- comprehensive patent search
Adalimumab- comprehensive patent searchKate Cleverley
 
Pharmaceutical Technology Transfer Best Practices
Pharmaceutical Technology Transfer Best PracticesPharmaceutical Technology Transfer Best Practices
Pharmaceutical Technology Transfer Best PracticesAnthony Grenier
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing ServiceVikram sathish Asokan
 
Pistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCS
Pistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCSPistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCS
Pistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCSPistoia Alliance
 
Eqalix, inc. product pipeline analysis
Eqalix, inc.   product pipeline analysisEqalix, inc.   product pipeline analysis
Eqalix, inc. product pipeline analysisAarkstore Enterprise
 
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-RegulationsHow-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-RegulationsAgaram Technologies
 
Fundability Criteria Worksheet_MediCoventures_v3.1
Fundability Criteria Worksheet_MediCoventures_v3.1Fundability Criteria Worksheet_MediCoventures_v3.1
Fundability Criteria Worksheet_MediCoventures_v3.1Aaron Call
 

Similar to Colesevelam patent search (20)

US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
 
Implementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentImplementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated Environment
 
Demo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationDemo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre Accreditation
 
Gaining business excellence by leveraging plm platform
Gaining business excellence by leveraging plm platformGaining business excellence by leveraging plm platform
Gaining business excellence by leveraging plm platform
 
Maintaining A Materials Declaration System
Maintaining A Materials Declaration SystemMaintaining A Materials Declaration System
Maintaining A Materials Declaration System
 
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
Best Practices: Cutting Through the Confusion & Avoiding the Pitfalls of Crea...
 
handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...
handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...
handbook_of_pharmaceutical_manufacturing_formulations__second_edition__volume...
 
Maetrics: The ROI of Good Quality & Compliance
Maetrics: The ROI of Good Quality & ComplianceMaetrics: The ROI of Good Quality & Compliance
Maetrics: The ROI of Good Quality & Compliance
 
Aagami Inc. Research Services Presentation
Aagami Inc. Research Services PresentationAagami Inc. Research Services Presentation
Aagami Inc. Research Services Presentation
 
Docmentation complete
Docmentation completeDocmentation complete
Docmentation complete
 
Generis Company Presentation for RIM
Generis Company Presentation for RIMGeneris Company Presentation for RIM
Generis Company Presentation for RIM
 
Adalimumab- comprehensive patent search
Adalimumab- comprehensive patent searchAdalimumab- comprehensive patent search
Adalimumab- comprehensive patent search
 
Pharmaceutical Technology Transfer Best Practices
Pharmaceutical Technology Transfer Best PracticesPharmaceutical Technology Transfer Best Practices
Pharmaceutical Technology Transfer Best Practices
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing Service
 
Data Integrity 101
Data Integrity 101Data Integrity 101
Data Integrity 101
 
Pistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCS
Pistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCSPistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCS
Pistoia Alliance RSC evening event 2015: Ian Berry, Evotec, on adopting CSCS
 
Eqalix, inc. product pipeline analysis
Eqalix, inc.   product pipeline analysisEqalix, inc.   product pipeline analysis
Eqalix, inc. product pipeline analysis
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-RegulationsHow-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
 
Fundability Criteria Worksheet_MediCoventures_v3.1
Fundability Criteria Worksheet_MediCoventures_v3.1Fundability Criteria Worksheet_MediCoventures_v3.1
Fundability Criteria Worksheet_MediCoventures_v3.1
 

Colesevelam patent search

  • 1. Colesevelam - Comprehensive patent search Report Details: Published:November 2012 No. of Pages: Price: Single User License – US$7200 Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information. Pipeline Developer features: •Comprehensive patent searching, covering the world's key territories (see 'search coverage' below) •Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified'below) •Patent identification, categorisation and interpretation •Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims •Manual filtration of patents not relevant to generic development •Updated on a monthly basis, including changes to patent families, statuses, and litigation •Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers Patent Categories Identified: 1. Molecular Form a) Molecule Patents b) Salts, Hydrates & Solvates c) Polymorphic Forms d) Other Molecular Forms 2. Active Ingredient Preparation a) Intermediates & Preparation Thereof b) Final Synthetic Stages c) Complete Synthesis d) Purification Methods
  • 2. e) Fermentation Methods f) Biotechnology 3. Formulations & Methods Thereof a) General Formulations & Methods b) Injectable Formulations c) Oral Formulations d) Other Administration-Specific Formulations e) Excipients, Kits & Packaging 4. Related Medical Use & Administration a) New Use Related to Main Indication b) Dosing Regimen/Administration Conditions 5. Active Ingredient Combinations a) Novel Combinations b) Use of Combinations c) Dosing Regimen & Administration Conditions for Combinations 6. Analytical Methods a) Assaying Methods b) Methods of Determining Patient Suitability Search coverage: Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries. Patent and national register access: Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind. Litigation alerts: Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgements where available. Updating: To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts. Legal status and transaction history: You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.
  • 3. Reporting and access: All data can be exported into Microsoft Excel and print friendly versions for ease of data manipulation and reporting. Company details are confidential and all data is SSL secure. Five users per company are permitted and access levels are controlled by a nominated 'company administrator'. Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite. Get your copy of this report @ http://www.reportsnreports.com/reports/206870-colesevelam--comprehensive-patent-search.html Major points covered in Table of Contents of this report include N/A Contact: sales@reportsandreports.com for more information.